Kevin Lo, Operating Partner at S2G (Photo Courtesy: PRNewswire)

SIBIONICS CGM Device – GS3 Debuts at ATTD 2025

SIBIONICS sales manager introduces the new product GS3 to the visitor. Image courtesy: PRNewswire
SIBIONICS sales manager introduces the new product GS3 to the visitor. Image courtesy: PRNewswire

The 2025 Advanced Technologies & Treatments for Diabetes (ATTD) conference took place in Amsterdam, Netherlands, bringing together top experts and the latest innovations in diabetes care. SIBIONICS participated in this prestigious event, unveiling one of the world’s thinnest CGM device—GS3, showcasing its latest breakthrough in glucose monitoring technology.

.

Image courtesy: LinkedIn

.

SIBIONICS GS3 Achieves CE Certification

With its ultra-compact design and 3-second activation, GS3 quickly became a highlight at ATTD 2025 with its revolutionary thinness of just 2.9mm, comparable to a small coin.

.

It offers:

  • Feather-light weight of only 1.5g, making it almost unnoticeable when worn
  • 3 connection methods, ensuring compatibility with a variety of smartphones
  • NFC-enabled 3-second connection, allowing instant pairing with a simple tap
  • By integrating multiple AI capabilities, GS3 helps users better understand their glucose data and enables more effective self-management of their glucose levels. In addition, GS3 can connect directly with Smartwatch and Receiver, meeting the personalized needs of a wider range of users, especially children and the elderly.
  • Continuous algorithm enhancements further improve monitoring stability and accuracy, providing a more reliable glucose management solution for users.

.

Logo courtesy: SIBIONICS LinkedIn

.

In-Depth Exploration of CGM & CKM in Clinical Applications

At ATTD 2025, SIBIONICS hosted the SIBIONICS Symposium, where experts shared research findings on the clinical applications of CGM and the differentiation of AGP (Ambulatory Glucose Profile) patterns among various patient groups. These insights contribute to the advancement of precision diabetes treatment and offer stronger scientific and clinical support.

CKM made its debut at the symposium, where clinical experts conducted an in-depth study on its potential for Type 1 diabetes management and, for the first time, shared preliminary findings at the conference.

With the launch of GS3, SIBIONICS continues to lead CGM innovation, aiming to provide a lighter, more precise, and smarter glucose monitoring experience for people with diabetes worldwide.

Source

For more news:

Smart Gadgets that Help to Keep You in Good Health

(Visited 123 times, 1 visits today)

Share:

Facebook
Twitter
WhatsApp
LinkedIn

 

Comments are closed.

Social Media

Most Popular

ChronarPay - Real-Time B2B ERP Payment Portal (Image Courtesy: PRNewswire)
CNBS ePAY Rebrands as ChronarPay
Cunard’s latest programme includes 195 new itineraries between April 2027 and January 2028 (Image Courtesy: PRNewswire)
Luxury Bookings Drive Strong Trading Following Cunard's 2027 Programme Launch
Trucordia Names Leanne Ross as Senior Vice President, National Sales Leader (Image Courtesy: PRNewswire)
Trucordia Names Leanne Ross as Senior Vice President, National Sales Leader
Blockdaemon Appoints Alex Zinder as Chief Product Officer (Image Courtesy: Blockdaemon Official website)
Blockdaemon Appoints Alex Zinder as Chief Product Officer

Related Posts